https://doi.org/10.4081/monaldi.2023.2637
Paraskeletal plasmacytoma presenting as a chest wall mass
Submitted: May 15, 2023
Accepted: June 29, 2023
Published: July 28, 2023
Accepted: June 29, 2023
Abstract Views: 352
PDF: 22
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Extramedullary involvement in multiple myeloma is uncommon. It can present as a plasma cell mass in the soft tissue surrounding the bony structures through direct extension or in various other organs via hematogenous spread. Here, we report a case of paraskeletal plasmacytoma that manifested as a chest wall mass in a 60-year-old man.
van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet 2021;397:410-27.
Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 2022;97:1086-107.
Jagosky MH, Usmani SZ. Extramedullary disease in multiple myeloma. Curr Hematol Malig Rep 2020;15:62-71.
Varettoni M, Corso A, Pica G, et al. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol 2010;21:325-30.
Weinstock M, Ghobrial IM. Extramedullary multiple myeloma. Leuk Lymphoma 2013;54:1135-41.
Bladé J, Beksac M, Caers J, et al. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer J 2022;12:45.
Rosiñol L, Beksac M, Zamagni E, et al. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. Br J Haematol 2021;194:496-507.
Dimopoulos MA, Hillengass J, Usmani S, et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 2015;33:657-64.
Lu YY, Chen JH, Lin WY, et al. FDG-PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma: a systematic review and metaanalysis. Clin Nucl Med 2012;37:833-7.
Hussong JW, Perkins SL, Schnitzer B, et al. Extramedullary plasmacytoma. A form of marginal zone cell lymphoma?. Am J Clin Pathol 1999;111:111-6.
Saha R, Bhattacharya A, Deb J, et al. Multiple myeloma presenting as thoracic plasmacytoma - two rare cases. Egypt J Chest Dis Tuberc 2014;63:267-71.
Lok R, Golovyan D, Smith J. Multiple myeloma causing interstitial pulmonary infiltrates and soft-tissue plasmacytoma. Respir Med Case Rep 2018;24:155-7.
Yuan H, Lei H, Gu P, et al. A rare case of extramedullary multiple myeloma presenting as masses on the breast and chest wall complicated with Sjogren’s syndrome. Int J Gen Med 2021;14:51-5.
Tazi I, Nafil H, Mahmal L. Chest wall tumor at relapse of multiple myeloma. Afr Health Sci 2013;13:160-1.
Pour L, Sevcikova S, Greslikova H, et al. Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse. Haematologica 2014;99:360-4.
Beksac M, Seval GC, Kanellias N, et al. A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome. Haematologica 2020;105:201-8. Erratum in: Haematologica 2021;106:1228.
How to Cite
Mallik, Sonali, Ananda Datta, and Debahuti Mohapatra. 2023. “Paraskeletal Plasmacytoma Presenting As a Chest Wall Mass”. Monaldi Archives for Chest Disease 94 (2). https://doi.org/10.4081/monaldi.2023.2637.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.